epiglucan and Testicular-Diseases

epiglucan has been researched along with Testicular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Testicular-Diseases

ArticleYear
Favourable effect of β-glucan treatment against cisplatin-induced reproductive system damage in male rats.
    Andrologia, 2019, Volume: 51, Issue:9

    The aim of this study was to investigate the potential beneficial effects of β-glucan treatment against oxidative, histological and spermatological damage caused by cisplatin on the male reproductive system. Twenty-eight Sprague Dawley male rats were used in the study. The rats were randomly divided into four equal-sized groups: a control group, cisplatin group (7 mg/kg in a single-dose cisplatin administered intraperitoneally), β-glucan group (β-glucan given at a dose of 50 mg kg

    Topics: Animals; Antineoplastic Agents; Antioxidants; beta-Glucans; Cisplatin; Disease Models, Animal; Epididymis; Humans; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sperm Count; Sperm Motility; Testicular Diseases; Testis; Thiobarbituric Acid Reactive Substances

2019